Eton Pharmaceuticals (ETON) Intangibles (2019 - 2025)

Eton Pharmaceuticals (ETON) has 7 years of Intangibles data on file, last reported at $30.9 million in Q4 2025.

• For the quarter ending Q4 2025, Intangibles fell 11.48% year-over-year to $30.9 million; the trailing twelve-month figure through Dec 2025 stood at $30.9 million (down 11.48% YoY), and the FY2025 full-year result was $30.9 million, down 11.48% from the prior year.
• Intangibles retreated to $30.9 million in Q4 2025, from $31.9 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $34.9 million in Q4 2024 to a low of $463000.0 in Q3 2021.
• A 5-year average of $11.1 million and a median of $4.7 million in 2022 frame the typical range for Intangibles.
• Across the five-year window, Intangibles fell 24.35% in 2021 and jumped 974.08% in 2022, its largest moves.
• Tracing ETON's Intangibles over 5 years: stood at $3.6 million in 2021, then surged by 31.29% to $4.8 million in 2022, then declined by 0.32% to $4.7 million in 2023, then soared by 636.04% to $34.9 million in 2024, then slipped by 11.48% to $30.9 million in 2025.
• Business Quant data shows ETON's Intangibles at $30.9 million in Q4 2025, $31.9 million in Q3 2025, and $32.9 million in Q2 2025.